A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease.
about
Molecular biology and pathogenicity of mycoplasmasIncreased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis.Introduction to immunology and autoimmunity.Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases.Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1.Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus.Role of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factorsThe Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide.Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients.Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.Clinical comments and a pathophysiological discussion of scleroderma.Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals.Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitisCellular and molecular mechanisms of autoimmune disease.Staphylococcal enterotoxins in the etiopathogenesis of mucosal autoimmunity within the gastrointestinal tract.Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule.Bacterial pyrogenic exotoxins as superantigens.Expression of the superantigen Mycoplasma arthritidis mitogen in Escherichia coli and characterization of the recombinant protein.Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5.Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cellOverexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?Human T-cell responses to Mycoplasma arthritidis-derived superantigen.The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines.In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II.Evidence for involvement of superantigens in human periodontal diseases: skewed expression of T cell receptor variable regions by gingival T cells.Superantigen influence in conjunction with cytokine polymorphism potentiates autoimmunity in systemic lupus erythematosus patients.
P2860
Q24548575-C7EB5BCF-95D8-407B-BE9A-334E9C634867Q33578311-C172128E-A04F-4B2A-893F-5B9B02BF6E60Q33741149-FDC59D0C-F574-4FFC-A845-FBE1252164BCQ33805908-6566696C-DD06-4EB6-8DE8-6E6205D144EFQ33890774-2C3B1A91-3385-4AD5-87B7-5614FB6F842EQ34007530-626E7A16-A207-4771-A84A-241300AEC56AQ34183950-1EDDC104-BD57-4E21-B49B-9A93C712A9E0Q34235870-9FEB6728-42C8-4972-B5E9-F1B406E0E658Q34525449-B902FB20-A9F0-4E5B-864E-943F1DBC9A0DQ34547530-EE9338E2-6225-42BA-99E1-D57BE1A22646Q35548993-C2014E81-A539-47E4-A1D8-1909263D51DDQ35556488-C5F30B9F-6309-48CF-AA64-AB11C1B0689CQ35654907-4F48BFFF-BC84-4518-9CC9-E67FD138DFC8Q36362794-1642D34E-B5E8-4A1A-A0FB-1737E7AAC4FAQ36538434-8149FE96-84D7-4CE7-BF8D-98980D057099Q37959331-9DB9B0AC-0CDB-40A9-9B96-EC6F4D1728CCQ38207858-92BCDD01-8A08-4560-9F8C-9A437CFEDB9AQ39822860-6A76063B-7F21-4F09-BF36-C539B838DF0FQ39827387-C1B4ECA3-1C3A-417E-A7A0-91055618553FQ39831661-AFA759B4-80C8-4035-8CEF-DE86BFF62EA0Q40270122-8E6934A4-DB4F-45D8-845F-BDA38A71A1FBQ40396183-60778A2E-DF4A-4ACB-8752-29B52178273BQ41662766-22EE712D-FBF7-4740-B299-2C0F91CD3817Q41941637-36832391-5D22-4242-90B0-7362FE31CE76Q42930535-73874B73-8563-4504-AC83-19EAFD1D8D8CQ43660021-51CBA4D7-220F-4F6F-A874-B2940BD6BD05Q46692301-7C979D7E-7BE6-4312-973D-B3C6572A7FD1Q46789529-C186C491-81EE-4377-A985-39BA26B5D1B3Q53804977-EBF0069D-388A-483A-A627-0E5EF55D6925
P2860
A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A potential role for microbial ...... f systemic autoimmune disease.
@en
A potential role for microbial ...... f systemic autoimmune disease.
@nl
type
label
A potential role for microbial ...... f systemic autoimmune disease.
@en
A potential role for microbial ...... f systemic autoimmune disease.
@nl
prefLabel
A potential role for microbial ...... f systemic autoimmune disease.
@en
A potential role for microbial ...... f systemic autoimmune disease.
@nl
P2093
P356
P1476
A potential role for microbial ...... f systemic autoimmune disease.
@en
P2093
P304
P356
10.1002/ART.1780340412
P577
1991-04-01T00:00:00Z